TYPE 2 DIABETES MELLITUS (T2DM)
Clinical trials for TYPE 2 DIABETES MELLITUS (T2DM) explained in plain language.
Never miss a new study
Get alerted when new TYPE 2 DIABETES MELLITUS (T2DM) trials appear
Sign up with your email to follow new studies for TYPE 2 DIABETES MELLITUS (T2DM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smart system helps nurses and doctors stop dangerous low blood sugar in hospital diabetes patients
Disease control CompletedThis study tested whether a team of doctors and nurses, guided by an intelligent early-warning system, could reduce dangerous low blood sugar (hypoglycemia) in hospitalized adults with type 2 diabetes who were using insulin pumps. Over 1,200 participants were monitored and receiv…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated May 26, 2026 03:22 UTC
-
Ancient ayurveda meets modern diabetes: 12-Week program shows promise
Disease control CompletedThis study tested whether a 12-week program combining an Ayurvedic diet, yoga, and breathing exercises was practical and helpful for adults with Type 2 Diabetes. Seventeen people started, and twelve finished. Most were able to follow the program, and they saw improvements in bloo…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Maharishi International University • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
Tailored diet shows promise for diabetes control
Disease control CompletedThis study tested whether intensive, personalized nutrition counseling can help adults with type 2 diabetes better control their blood sugar, reduce inflammation, and improve gut health. Forty adults were split into two groups: one received weekly one-on-one diet plans for 12 wee…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Serap Balaban Barta • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Generic diabetes pill put to the test against Brand-Name trijardy
Disease control CompletedThis study checked if a new generic pill containing three diabetes medicines (empagliflozin, linagliptin, and metformin) works the same as the brand-name pill Trijardy XR. Fourteen healthy adults took a single dose of each pill in random order. Researchers measured drug levels in…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Can a new vitamin B12 pill fix a common diabetes drug side effect?
Disease control CompletedThis study tested whether a special form of vitamin B12 (Sucrosomial® B12) can safely raise low B12 levels in adults with type 2 diabetes who have been taking metformin for at least a year. Fifty participants received either the vitamin or a placebo daily for 4 weeks. The goal wa…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
Magnetic bypass: a new tool against obesity and diabetes?
Disease control CompletedThis study tested a new magnetic system (MagDI) that creates a connection in the small intestine to help with weight loss and type 2 diabetes. 27 adults with obesity (BMI 30-50) and some with diabetes took part. The goal was to see if the device could be placed safely and work as…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: GT Metabolic Solutions, Inc. • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
Herbal combo shows promise for blood sugar control in diabetes
Disease control CompletedThis study tested whether taking a combination of bitter melon extract and snakehead fish powder for four weeks could help lower blood sugar in adults with type 2 diabetes. Eighty participants from community health centers in Indonesia took either the supplement or a placebo. The…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Universitas Muhammadiyah Surakarta • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New diabetes shot shows promise in Mid-Stage trial
Disease control CompletedThis study tested a new injectable medicine called UBT251 in 211 adults with type 2 diabetes who were already taking metformin. The goal was to see if it improves blood sugar control over 24 weeks and to find the best dose for future larger studies. Participants received either U…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE2 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
One pill vs. two: new combo drug may simplify diabetes care
Disease control CompletedThis study tested whether a single pill containing two diabetes drugs (dapagliflozin and metformin) works as well as taking them separately in Chinese adults with type 2 diabetes. Over 600 participants took either the combo pill or the two separate pills for 24 weeks. The main go…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Vitamin d pills tested for better diabetes control
Disease control CompletedThis study looked at whether giving vitamin D supplements to adults with type 2 diabetes and low vitamin D levels improves their blood sugar control. 119 participants took a high dose of vitamin D once a month for three months. Researchers measured blood sugar and HbA1c levels be…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Faculty of Medical Sciences, Clinical Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Phone coaching boosts diabetes Self-Care in new study
Disease control CompletedThis study looked at whether giving adults with type 2 diabetes extra education and follow-up phone calls helps them manage their diabetes better, stick to their treatment, and feel more confident about their medications. 70 adults were split into two groups: one got the extra su…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Selcuk University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Magnetic bowel bypass: a new tool against obesity and diabetes?
Disease control CompletedThis study tested a new magnetic system (MagDI) in 10 adults with obesity and type 2 diabetes. The device creates a new connection in the small bowel to help with weight loss and blood sugar control. The main goals were to see if the procedure is safe and works as intended, witho…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: GT Metabolic Solutions, Inc. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
ER alerts for diabetes: a simple prompt that could change care
Disease control CompletedThis study tested whether electronic alerts in the emergency department help doctors start diabetes care sooner. 300 adults with high blood sugar were included. The alerts prompted doctors to order additional tests and arrange follow-up appointments. The goal was to see if this l…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Free meals and grocery vouchers may improve health in struggling families
Disease control CompletedThis study tested whether providing medically tailored meals, grocery vouchers, or a combination can improve health in low-resource families. 56 adults and children with food insecurity and conditions like type 2 diabetes or high blood pressure took part. Researchers measured cha…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Alison Gustafson • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New weekly shot shows promise for weight loss and diabetes control
Disease control CompletedThis study tested a new once-weekly injection called MET097 in 133 adults who are overweight or have obesity and also have type 2 diabetes. The goal was to see if it helps with weight loss and improves blood sugar levels compared to a placebo over 28 weeks. Participants received …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE2 • Sponsor: Metsera, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Can your phone help control diabetes? study tests digital coaching
Disease control CompletedThis study tested whether a digital support program could help people with type 2 diabetes manage their condition better. For six months, one group of participants received nurse-led education and regular reminders on their smartphones about medication, diet, and exercise. Resear…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Alanya Alaaddin Keykubat University • Aim: Disease control
Last updated Apr 14, 2026 13:09 UTC
-
Spiritual care boosts emotional health in diabetes patients
Symptom relief CompletedThis study tested whether adding spiritual care to standard diabetes treatment helps adults over 40 with type 2 diabetes. One group received regular care, while the other also got spiritual support from trained health workers. Researchers measured changes in emotional strength, s…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Universitas Noor Huda Mustofa • Aim: Symptom relief
Last updated May 26, 2026 03:20 UTC
-
Hypnosis boosts diabetes Self-Care in new study
Symptom relief CompletedThis study tested a program called HypnoDiaCare, which combines hypnosis with diabetes education, to see if it helps adults with type 2 diabetes manage their condition and improve quality of life. Fifty-four participants were split into three groups: one received hypnosis plus ed…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Gadjah Mada University • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC
-
Blood metal levels may link diabetes and gum disease
Knowledge-focused CompletedThis study looked at levels of three metals (chromium, nickel, and magnesium) in the blood of 74 adults with type 2 diabetes and gum disease. Researchers wanted to see if these metals are connected to gum health. The study did not test any treatment, only measured and compared th…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Knowledge-focused
Last updated May 26, 2026 03:20 UTC
-
New arabic tool helps diabetics protect their feet
Knowledge-focused CompletedThis study tested a new Arabic version of a questionnaire that measures how well people with type 2 diabetes take care of their feet. 255 adults in Tunisia completed the online survey. The goal was to see if the Arabic version is reliable and valid, so doctors can better identify…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: Faculty of Medicine, Sousse • Aim: Knowledge-focused
Last updated May 26, 2026 03:11 UTC
-
Blood protein may predict best diabetes treatment for fatty liver
Knowledge-focused CompletedThis study looked at 130 adults with type 2 diabetes and fatty liver disease to see if a blood protein called adiponectin can help predict which diabetes medicines work best for reducing liver fat. Participants received one of three treatments (SGLT2 inhibitors, GLP-1 agonists, o…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Moscow Regional Research and Clinical Institute (MONIKI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:09 UTC
-
Generic diabetes combo drug put to the test against Brand-Name synjardy
Knowledge-focused CompletedThis study checked whether a new generic version of a combination diabetes pill (empagliflozin and metformin) releases the same amount of medicine into the body as the brand-name Synjardy XR. Forty healthy adults took a single dose of each pill under fed conditions, and researche…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC
-
Sugar watch: new study links Mom's glucose to Baby's birth risks
Knowledge-focused CompletedThis study looked at 80 pregnant women with type 2 diabetes who used a continuous glucose monitor (CGM). Researchers wanted to see if blood sugar patterns were linked to health problems in newborns, like early birth or low blood sugar. The goal was to better understand how diabet…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC
-
New diabetes drug tested in kidney patients
Knowledge-focused CompletedThis study looked at how the body handles BGM0504, a potential treatment for type 2 diabetes and obesity, in people with different levels of kidney function. Researchers compared 34 participants with normal kidneys to those with mild or moderate kidney impairment. The goal was to…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE1 • Sponsor: BrightGene Bio-Medical Technology Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC
-
Early safety check for new diabetes drug combo
Knowledge-focused CompletedThis early-phase study tested how two experimental drugs (L03RD1 and L03RD2) move through the body and their safety when given together or as a single combined drug (CT-L03). It involved 49 healthy adults aged 19-55. The goal was to gather basic information, not to treat diabetes…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE1 • Sponsor: Celltrion • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
AI uncovers Exercise's secret power on gut health in diabetes
Knowledge-focused CompletedThis study looked at how exercise affects gut bacteria in people with type 2 diabetes. 79 adults were split into two groups: one did aerobic and resistance exercise for 16 weeks, the other stayed sedentary. Researchers used AI to predict changes in gut microbes and checked how th…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Shanghai 6th People's Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
What happens to your diet on weight-loss drugs? new study investigates.
Knowledge-focused CompletedThis study followed 37 adults who were about to start a GLP-1 medication (like Ozempic or Mounjaro) for weight or diabetes management. Researchers tracked their eating habits, side effects, and medication use over time. The goal was to see if it's possible to collect this kind of…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: Australian Catholic University • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC
-
Generic diabetes drug put to the test against Brand-Name synjardy XR
Knowledge-focused CompletedThis study checked if a generic version of the diabetes drug Synjardy XR (empagliflozin/metformin) is absorbed into the body the same way as the brand-name drug. It involved 32 healthy adults who took a single dose of each version under fasting conditions. The goal was to see if …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC
-
Blood sugar levels linked to brain and body decline in seniors
Knowledge-focused CompletedThis study looked at how prediabetes and type 2 diabetes impact memory, physical abilities, and fatigue in people aged 60 and older. Researchers compared 94 older adults with normal blood sugar, prediabetes, or diabetes using tests for thinking, walking, and tiredness. The goal w…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: Uşak University • Aim: Knowledge-focused
Last updated May 19, 2026 11:46 UTC
-
Taiwan study tests smart devices for senior health
Knowledge-focused CompletedThis study looked at whether using smart devices and a cloud platform can help middle-aged and older adults in Taiwan better manage health issues like high blood pressure, diabetes, and weight. About 199 people from four communities used devices to track their health data, which …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC